Across TCGA pan-cancer cohorts, TRAPPC2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TRAPPC2 data layer compared with 28 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TRAPPC2 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRAPPC2 expression acts as an unfavorable survival marker.

KIRP are the cancer types where TRAPPC2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.016	0.920	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TRAPPC2 tumor-vs-normal RNA expression · all TRAPPC2 data types